Do Self-Report and Physician Impressions of Adherence to Oral Antipsychotic Medication Agree With Objective Data?

NCT00223522 | Completed

• 1 other identifier: 034-0013-002
• Study Type: observational
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to prospectively examine adherence to oral atypical antipsychotics in patients with schizophrenia. We are psrticularly interested in examining the level of agreement among self-report, physician impressions and objective measures of adherence. We believe that physicians, casemanagers, and clients significantly overestimate the level of adherence.

Conditions

Schizophrenia; Schizoaffective

Keywords

Schizophrenia; Schizoaffective; MEMS; adherence to antipsychotic medication

Interventions

MEMS caps DEVICE

Eligibility Criteria

• Age: 18 Years - 55 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• Diagnosis of Schizophrenia or Schizoaffective disorder
• Between the ages of 18-55
• no documented history of head injury, mental retardation or neurological disorder

Sponsors & Collaborators

• The University of Texas Health Science Center at San Antonio: lead
• Janssen Pharmaceutica N.V., Belgium: collaborator

Study Sites (1)

UTHSCSA

San Antonio, Texas, 78229, United States

Location

MeSH Terms

Conditions

Schizophrenia

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic Disorders; Mental Disorders

Study Officials

• Dawn I Velligan, Ph.D.

  University of Texas

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER

Study Record Dates

• First Submitted: September 14, 2005
• First Posted: September 22, 2005
• Study Start: April 1, 2004
• Study Completion: March 1, 2005
• Last Updated: September 22, 2005

Record last verified: 2005-09

Locations

US (1)